BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2969757)

  • 1. [Selective anticonvulsive action of N-substituted imidazole-4,5-dicarboxylic acids against quinolinic acid].
    Ryzhov IV; Lapin IP; Piotrovskiĭ LB; Aleksandrova IIa
    Biull Eksp Biol Med; 1988 Jul; 106(7):64-7. PubMed ID: 2969757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of antagonists of exciting amino acids on the neuro-destructive effect of quinolinic acid in vitro in comparison with their anticonvulsive action in situ].
    Khaspekov LG; Lapin IP; Ryzhov IV; Viktorov IV
    Biull Eksp Biol Med; 1989 Aug; 108(8):190-3. PubMed ID: 2529920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Synergism of picrotoxin with the endogenous convulsants kynurenine and quinolinic acid and its antagonism with their antagonists].
    Lapin IP; Ryzhov IV
    Farmakol Toksikol; 1985; 48(6):13-7. PubMed ID: 3002845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of anticonvulsants on convulsions induced by kynurenine, quinolinic acid, strychnine and corazole].
    Ryzhov IV; Lapin IP
    Biull Eksp Biol Med; 1981 Dec; 92(12):696-9. PubMed ID: 6459807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antagonism of L-glycine to seizures induced by L-kynurenine, quinolinic acid and strychnine in mice.
    Lapin IP
    Eur J Pharmacol; 1981 May; 71(4):495-8. PubMed ID: 7250201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of gamma-aminobutyric acid and its derivatives on convulsions induced by L-kynurenine and quinolinic acid].
    Ryzhov IV; Lapin IP
    Farmakol Toksikol; 1981; 44(2):140-3. PubMed ID: 6456152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of serotoninergic and antiserotoninergic preparations on convulsions induced by the endogenous convulsants kynurenine and quinolinic acid].
    Lapin IP
    Farmakol Toksikol; 1987; 50(5):15-8. PubMed ID: 2961608
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous antagonists of quinolinic acid and kynurenine as links of the defensive mechanism in epilepsy.
    Lapin IP
    Acta Neurol (Napoli); 1985; 7(3-4):203-6. PubMed ID: 2932891
    [No Abstract]   [Full Text] [Related]  

  • 9. Antagonism of seizures induced by the administration of the endogenous convulsant quinolinic acid into rat brain ventricles.
    Lapin IP; Prakhie IB; Kiseleva IP
    J Neural Transm; 1986; 65(3-4):177-85. PubMed ID: 2940335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The action of 3-indolepyruvate in quinolinate-induced convulsions in mice].
    Mirzaev S; Ryzhov IV
    Farmakol Toksikol; 1991; 54(5):10-1. PubMed ID: 1839285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Convulsions induced by kynurenine and quinolinic acid as a sensitive test for assessing the anticonvulsant activity of GABA-ergic preparations].
    Lapin IP; Ryzhov IV
    Biull Eksp Biol Med; 1983 Apr; 95(4):53-5. PubMed ID: 6299432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Stimulatory effects of intraventricular administration of kynurenines, amino acids, and convulsants: differences between rats and mice].
    Prakh'e IB; Kiseleva IP; Lapin IP
    Fiziol Zh SSSR Im I M Sechenova; 1982 Nov; 68(11):1516-21. PubMed ID: 7152052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Convulsant action of intracerebroventricularly administered l-kynurenine sulphate, quinolinic acid and other derivatives of succinic acid, and effects of amino acids: structure-activity relationships.
    Lapin IP
    Neuropharmacology; 1982 Dec; 21(12):1227-33. PubMed ID: 6218422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant action of beta-kainic acid in mice. Is beta-kainic acid an N-methyl-D-aspartate antagonist?
    Turski L; Meldrum BS; Collins JF
    Brain Res; 1985 Jun; 336(1):162-6. PubMed ID: 2860949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The neurodegenerative and convulsant action of quinolinic acid].
    Kozlovskiĭ VL; Prakh'e IV; Geĭnisman NV
    Neirofiziologiia; 1990; 22(3):354-9. PubMed ID: 2144614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
    Gasparini F; Bruno V; Battaglia G; Lukic S; Leonhardt T; Inderbitzin W; Laurie D; Sommer B; Varney MA; Hess SD; Johnson EC; Kuhn R; Urwyler S; Sauer D; Portet C; Schmutz M; Nicoletti F; Flor PJ
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1678-87. PubMed ID: 10336568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of some imidazole-4,5-dicarboxylic acid derivatives on the activity of N-methyl-D-aspartate (NMDA) receptors].
    Efremov OM; Aleksandrova IIa; Kulikov SV; Losev NA; Piotrovskiĭ LB
    Eksp Klin Farmakol; 2005; 68(1):7-9. PubMed ID: 15786955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavioral and EEG signs of the convulsive action of kynurenine and quinolinic acid in cats].
    Dutov AA; Tolpyshev BA
    Farmakol Toksikol; 1987; 50(3):33-6. PubMed ID: 2956122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the interaction of 2-amino-7-phosphono-heptanoic acid and quinolinic acid in mice.
    Perkins MN; Stone TW
    Eur J Pharmacol; 1983 May; 89(3-4):297-300. PubMed ID: 6347698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacologic modulation of central noradrenergic mechanisms and the effect of selected substances on chemically-induced seizures: the maximal quinolinic acid seizure test (mouse)].
    Fischer W; Ryzov IV; Lapin IP
    Pharmazie; 1991 Apr; 46(4):301-3. PubMed ID: 1832228
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.